Latest news with #AIM
The Star
5 hours ago
- General
- The Star
Mozambique launches beekeeping project for wildlife protection, rural income growth
MAPUTO, July 28 (Xinhua) -- Mozambican authorities have launched a beekeeping project near Magoe National Park in Tete Province to produce 100 tonnes of honey annually, while reducing human-wildlife conflict and promoting sustainable livelihoods for nearby communities, local media reported on Monday. According to Mozambique's state news agency AIM, the Community Economic Empowerment Project, with a budget of 20 million meticais (about 316,105 U.S. dollars), is being implemented in the buffer zone of the park. The project includes the installation of 4,000 beehives, training programs for community members, and the establishment of a honey processing facility. Nelson Antonio, director of the Technical and Financial Assistance Services of the Zambezi Valley Development Agency, revealed that the initiative serves to generate income and act as a natural deterrent to elephants. "Elephants are afraid of bees. Studies show they avoid areas with hives because bee stings to sensitive areas such as the eyes, trunk, and ears are extremely painful," he said. "By placing hives along fences surrounding farmland, we create a living barrier. If an elephant touches the fence and disturbs the bees, it will retreat, thus helping prevent crop damage," Antonio explained. Antonio also noted that the project provides alternative economic opportunities, reducing the reliance on unsustainable practices such as poaching and illegal logging within protected areas. "With sustainable sources of income, communities are less likely to engage in illegal wildlife hunting," he added. Mozambican Secretary of State for Marine Affairs and Fisheries Momade Juizo emphasized the project's social impact, noting that about 500,000 households are expected to benefit from it.
Time of India
3 days ago
- Sport
- Time of India
Liplin wins blitz gold; Mikail enjoys sole lead in standard
Panaji: FM Liplin Llia (Russia) won gold at the 24th World IPCA Blitz Chess Championship in Dona Paula, on Friday. IM Eugenio Campos (Angola) won silver scoring seven points while FM Soltanov Serik (Kazakhstan) also scored seven points and was awarded the bronze. Tired of too many ads? go ad free now 89 players from 16 countries took part in the blitz competition. Liplin remained undefeated scoring eight points out of nine, winning seven and drawing the other two. He defeated FM Sargissyan Sargis (Armenia) and FM Soltanov Serik (Kazakhstan), while drawing with IM Eugenio Campos of Angola, amongst others. In the standard section, the battle for the top spot is heating up with Dzenisenia Mikail (Russia) leading with five points, winning all his games till now. Playing on the first board with white pieces, he defeated Lipilin in a Sicilian opening manoeuvre in only 22 moves to take the sole lead. IM Molenda Marcin (Poland), the leader after four rounds, follows close behind in second place with 4.5 pts. Liplin is in third place with four points. Others on four points include Anfinogenov Artem (Russia), FM Sargissyan Sargis (Armenia), Glazar Domagoj (Croatia), Ayapov Alimzhan (Kazakhstan), Khishigbayar Mijgee (Mongolia), FM Venkata Krishna Karthik K (India), AIM Sundui Sonom (Mongolia) and Rakhtibekov Tilegen (Kazakhstan). The 24th World IPCA Chess Championship continues till next week, with 97 participants from 17 countries competing in the championship being staged in Asia for the first time.
Business Upturn
3 days ago
- Business
- Business Upturn
Endoscopic AI: AI Medical Service Inc. Has Obtained Regulatory Approval from Thailand's FDA for Its Gastric AI-based Endoscopic Diagnosis Support System
Business Wire India AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, is excited to announce that it has received medical device approval from the Thai Food and Drug Administration (Thai FDA) on June 26, 2025. The approval is for its endoscopic image diagnosis support software, the "gastroAI-model G." This system utilizes artificial intelligence to assist physicians in differentiating between neoplastic and non-neoplastic gastric lesions within endoscopic images. This marks the first time in Thailand that an AI-powered diagnostic support system for the upper gastrointestinal tract, equipped with lesion differentiation1 capabilities, has received regulatory approval2. This press release features multimedia. View the full release here: Software image Background of our efforts to complete regulatory review and device registration in Thai Gastric cancer is the fifth most common cancer in the world, with more than 1 million people contracting gastric cancer and approximately 600,000 people dying from the disease each year3. Gastric cancer is characterized by a mortality rate that increases significantly with disease progression. However, gastric cancer is very often treatable if detected at an early stage; the 5-year relative survival rate is approximately 95% if detected at stage I, but less than 50% if detected at stage III or later4. Nevertheless, early-stage gastric cancer is difficult to detect and is said to be missed in 4.5 to 25.8% of cases5. In Thailand, the high mortality rate for gastric cancer (approximately 75%6 of diagnosed individuals die from the disease) suggests that many cases are detected at an advanced stage. This healthcare challenge is compounded by significant demographic trends; as a member of the Global South, Thailand is experiencing economic growth and a rising life expectancy. For example, the current average life expectancy of around 76 years7 is one factor that contributes to Thailand having one of the most rapidly aging populations in the ASEAN region. According to the United Nations' World Population Prospects (2024), Thailand's population has peaked and is expected to decline in the future. Consequently, the need for effective cancer countermeasures, including for gastric cancer, is expected to rise concurrent to aging demographics. By delivering our gastric cancer diagnostic support AI leveraging Japan's world-leading endoscopic medical technology to the clinical frontline in Thailand, we aim to address the anticipated shortage of endoscopy specialists and ultimately contribute to reducing the number of deaths from gastric cancer. About gastric cancer differentiation AI 'Endoscopic image diagnosis support software – gastroAI-model G' The gastric cancer differentiation AI, brand-named 'Endoscopic image diagnosis support software – gastroAI-model G,' is a diagnosis support system for determining the neoplastic or non-neoplastic nature of gastric lesions. The system analyzes endoscopic still images acquired during endoscopic examination and provides near-instant feedback to the physician. The software indicates whether the candidate lesion featured in the image is likely neoplastic ('Adenoma or Adenocarcinoma'), likely non-neoplastic, or unlikely to be neoplastic ('Low Confidence')8. If the lesion in the image is neoplastic, the degree of visual similarity between it and historical neoplastic lesions (confidence level) is displayed, and a rectangle indicating the location of the lesion is superimposed onto the image. Brand name: Endoscopic image diagnosis support software – gastroAI-model G Approval Number: 68-2-2-2-0006282 About AI Medical Service Inc. AI Medical Service is a med-tech company and healthcare startup guided by the mission to "Save Lives All Over the World." Japan is a world leader in the field of endoscopy, with an accumulation of world-class data in both quality and quantity. We are engaged in product research and development that leverages this data, and we aim to save patients worldwide by swiftly delivering the results of these efforts to clinical settings. Company Company: AI Medical Service Inc. Address: Hareza Tower 11F, 1-18-1 Higashi-ikebukuro, Toshima-ku, Tokyo 170-0013, Japan Executive Leadership: Tomohiro Tada, Yasushi Takigawa Founding: September 1, 2017 Business: Development of endoscopic AI (artificial intelligence) to support diagnostic imaging and related activities
Time of India
4 days ago
- Business
- Time of India
‘Land received in exchange by Gyanvapi mosque to be put to commercial use'
1 2 Varanasi: The 1,000 square feet land received from the Kashi Vishwanath temple by Gyanvapi mosque in exchange for its land, where Gate-4 of Kashi Vishwanath Dham exists, will be used for commercial activities. Gyanvapi mosque management committee, Anjuman Intezamia Masajid, engaged architects on Wednesday to measure land and prepare design of a building for commercial use on land received in exchange for the temple, AIM joint secretary S M Yaseen told TOI on Thursday. The temple purchased a building of 1,900 square feet near its Bansphatak office and 1,000 square feet of it was given to the AIM against land it gave to the temple during the rejuvenation of KV Dham in 2021. Yaseen said, "It was decided to utilise the land received from the temple for commercial purposes, while funds generated by the proposed commercial building will be used for mosque work." Following two years of negotiation, AIM and Shri Kashi Vishwanath Temple Trust (SKVTT) had in Jul 2021 agreed to exchange land. The AIM and Muslim community announced giving its land measuring 1,700 square feet near the then Chhattadwar entry point of the Kashi Vishwanath-Gyanvapi complex. In return, the temple administration gave a piece of land measuring 1,000 square feet of the same value to the AIM. The exchange deal was finalised on Jul 9, 2021, when papers were signed by the then chief executive officer of the temple, Sunil Kumar Verma, on behalf of UP Governor and the AIM representative Maulana Abdul Batin Nomani. Property given by Muslim side was owned by Uttar Pradesh Central Sunni Wakf Board, while the Gyanvapi-KVT control room existed there before it was removed for fresh construction of KV Dham. "It took almost two years for the exchange deal to materialise," said Yaseen, adding that permission of the Sunni Central Waqf Board and the opinion of all clerics were taken before the deal. Yaseen said decision for exchange of property was taken after seeking consent of various religious authorities and also the Waqf Board. While finalising the land exchange in 2021, officials and Yaseen made it clear that such cases had nothing to do with this deal and expressed hope that it would send out a message of communal harmony. Following the land swap, the way was paved for construction of Gate-4 and other structures of the rejuvenated KV Dham. When the deal for the exchange of land was finalised between the temple and mosque, hearings in many petitions, including original suit no. 610/1991, filed by three litigants and now being contested by advocate Vijay Shankar Rastogi as next friend of the deity, to seek the removal of the mosque from Gyanvapi land, and also suit no 693/2021 Rakshi Singh and others vs UP state and others, in which five women were seeking worship of Shringar Gauri and other deities on Gyanvapi premises, were in progress in different courts.
Yahoo
5 days ago
- Business
- Yahoo
UK Penny Stocks To Watch In July 2025
The UK market has recently faced challenges, with the FTSE 100 index declining due to weak trade data from China, highlighting global economic uncertainties. Amid these fluctuations, investors often look for stocks that combine affordability with growth potential. Penny stocks, though an older term, remain relevant as they often represent smaller or newer companies with strong financials and the potential for significant returns. Top 10 Penny Stocks In The United Kingdom Name Share Price Market Cap Financial Health Rating FRP Advisory Group (AIM:FRP) £1.20 £295.18M ★★★★★☆ Foresight Group Holdings (LSE:FSG) £4.57 £509.93M ★★★★★★ Warpaint London (AIM:W7L) £4.15 £334.46M ★★★★★★ Van Elle Holdings (AIM:VANL) £0.396 £41.66M ★★★★★★ System1 Group (AIM:SYS1) £4.25 £53.29M ★★★★★★ LSL Property Services (LSE:LSL) £3.05 £313.97M ★★★★★☆ Begbies Traynor Group (AIM:BEG) £1.255 £195.17M ★★★★★★ Croma Security Solutions Group (AIM:CSSG) £0.82 £11.29M ★★★★★★ Braemar (LSE:BMS) £2.31 £70.75M ★★★★★★ ME Group International (LSE:MEGP) £2.17 £827.08M ★★★★★★ Click here to see the full list of 301 stocks from our UK Penny Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Helios Underwriting Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Helios Underwriting plc, along with its subsidiaries, offers limited liability investment opportunities for shareholders in the Lloyd's insurance market in the UK and has a market cap of £157.38 million. Operations: The company's revenue segment is derived entirely from the United Kingdom, totaling £36.00 million. Market Cap: £157.38M Helios Underwriting plc, with a market cap of £157.38 million, is trading at a price-to-earnings ratio of 8.5x, which is below the UK market average, indicating potential value for investors. Despite recent negative earnings growth and declining profit margins from 86.9% to 51.6%, the company maintains satisfactory debt levels with a net debt to equity ratio of 17.1%. The board and management team are relatively new, suggesting ongoing strategic shifts as evidenced by recent executive changes and restructuring efforts aimed at reducing underwriting risk and costs for 2025. Take a closer look at Helios Underwriting's potential here in our financial health report. Assess Helios Underwriting's future earnings estimates with our detailed growth reports. Journeo Simply Wall St Financial Health Rating: ★★★★★★ Overview: Journeo plc offers solutions for the transport sector by capturing, processing, and displaying critical information to improve travel experiences in the UK and internationally, with a market cap of £73.65 million. Operations: The company's revenue is generated through its segments: Infotec (£12.42 million), Journeo A/S (£4.03 million), Fleet Systems (£23.69 million), and Passenger Systems (£9.50 million). Market Cap: £73.65M Journeo plc, with a market cap of £73.65 million, demonstrates financial stability as its short-term assets (£33.7M) exceed both short-term (£17.1M) and long-term liabilities (£7.7M). The company's high Return on Equity (26.1%) and quality earnings reflect strong operational performance, while recent contracts bolster its growth prospects. Notably, Journeo secured a minimum £1.2 million contract with Umove in Denmark for Intelligent Transport Systems and a €4.2 million order from Alstom SA for CCTV systems on CrossCountry's Voyager fleets in the UK, enhancing its revenue pipeline through significant SaaS opportunities over coming years. Unlock comprehensive insights into our analysis of Journeo stock in this financial health report. Evaluate Journeo's historical performance by accessing our past performance report. Zotefoams Simply Wall St Financial Health Rating: ★★★★★★ Overview: Zotefoams plc, along with its subsidiaries, manufactures, distributes, and sells polyolefin foams across the United Kingdom, Europe, North America, and internationally; it has a market cap of £156.41 million. Operations: The company's revenue is primarily derived from High-Performance Products (£79.64 million), Polyolefin Foams (£66.93 million), and Mucell Extrusion LLC (£1.22 million). Market Cap: £156.41M Zotefoams plc, with a market cap of £156.41 million, is currently unprofitable but maintains financial stability as its short-term assets (£72.0M) exceed both short-term (£51.9M) and long-term liabilities (£13.5M). The company's debt is well covered by operating cash flow (72.3%), and it has not meaningfully diluted shareholders recently. While the dividend yield of 2.33% isn't fully supported by earnings, Zotefoams' recent executive changes, including appointing Nick Wright as Group CFO, signal a strategic focus on financial management and growth potential in high-performance products and polyolefin foams sectors internationally. Jump into the full analysis health report here for a deeper understanding of Zotefoams. Understand Zotefoams' earnings outlook by examining our growth report. Seize The Opportunity Reveal the 301 hidden gems among our UK Penny Stocks screener with a single click here. Seeking Other Investments? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:HUW AIM:JNEO and LSE:ZTF. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
